The multifaceted roles of cyclophilin C in human diseases: Molecular mechanisms and therapeutic potential from non-neoplastic diseases to malignancies

Read full text Summarise with VIRAT
Authors: Zehua Zhao, Xiaozhuo Gao, Fujing Sun, Tianming Li, Yuan Yuan, Yanmei Zhu
Cited by: 0
References: 90

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This review article primarily focuses on the multifaceted roles of Cyclophilin C (CypC) in various human diseases including both non-neoplastic diseases and malignancies. CypC, a member of the cyclophilin family, exhibits peptidyl-prolyl cis-trans isomerase and apoptotic nuclease activities and is involved in endoplasmic reticulum redox homeostasis. In non-neoplastic diseases, CypC serves as a biomarker for coronary artery disease (CAD) through its proinflammatory effects and its impact on vascular endothelial dysfunction. It also protects brain tissue from ischemic injury and aids human cytomegalovirus (HCMV) in evading immune surveillance, leading to chronic infection. The gene encoding CypC, PPIC, is implicated in glycemic control, liver fibrosis, and chronic obstructive pulmonary disease (COPD). In the context of malignancies, although fewer studies have been reported, CypC's roles in ovarian cancer, gastric cancer, breast cancer, melanoma, and gliomas highlight its potential as a candidate biomarker and a potential target requiring further validation. This review aims to comprehensively elucidate the role and molecular mechanisms underlying CypC's involvement in these diseases, thereby contributing to the identification of novel targeted therapies.

Fields of Study & Subjects

Signaling Pathways in Disease Cancer-related Molecular Pathways Circular RNAs in diseases

Publication details

Journal / source
Genes & Diseases
Pages
102151–102151
Publication date
1 March 2026
Language
EN